HIV prevention for young women getting reproductive health care
Part of Immune system & allergy, Infections clinical trials.
This study offers different forms of HIV prevention medicine (PrEP) to young women ages 18–30 who are visiting clinics for reproductive health services like family planning or postnatal care. It aims to see which delivery method works best for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 30 years old.
- You are visiting a participating clinic for reproductive health care (like family planning, check-ups after childbirth, or maternal health).
- You are willing to talk through the study details and give your permission to join.
- You can speak and understand either Kiswahili or English.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study offers a way for adolescent girls and young women in Tanzania to get PrEP (a daily pill that helps prevent HIV) from local pharmacies instead of only from clinics. It aims to make starting and staying on PrEP easier and more convenient.
This study tests a program to help women at risk for HIV get PrEP, a medicine that prevents HIV. It focuses on women who may want to have a child or have been pregnant recently.
This study aims to expand access to PrEP (a daily pill that prevents HIV) for pregnant and postpartum women visiting maternal and child health clinics in Kenya. It also includes health care workers who provide PrEP services.
This study tests ways to help young people in Uganda prevent HIV or stay healthy if they already have HIV. It offers free prevention pills or injections and care for those living with HIV.
This study tests a program called PrEP Choice to help young people learn about and start PrEP, a daily pill that prevents HIV. It aims to see if offering choices in PrEP care makes it easier to use.
This study tests a program to help young women and girls stick with their HIV prevention medication (PrEP). It explores whether extra support can make it easier to stay on PrEP and protect against HIV.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.